RxDoctor Payments Data

Sarah Taylor

Optometrist · South Charleston, WVNPI 1063403459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 25.8% of the total.

$1,348in general payments, 2019–2025

Across 31 payments — averaging $43.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$348
  • Alcon$318
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$178
  • Sun Pharmaceutical Industries Inc.$153
  • Kala Pharmaceuticals, Inc.$125
  • Dompe US, Inc.$117
  • plus $107 from 2 others
$62,244in ownership & investment interests, 2019–2025

Across 5 payments — averaging $12,449 each. An ownership or investment interest held by the physician or an immediate family member.

  • The North Carolina Mutual Wholesale Drug Company Inc$62K

What the payments were for

  • Food & beverage$1,348100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,348 in reported general payments places this provider in the 60th percentile of 210 optometrist providers in West Virginia.

See all optometrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$11,536
Medicare patients
87
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine12$22,333
Latanoprost31$434

Paid to pharmacies, not to this prescriber.

Other optometrist in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →